BamSEC and AlphaSense Join Forces
Learn More

Crinetics Pharmaceuticals Inc. – Material Contracts

NASDAQ: CRNX    
Share price (6/24/26): $36.18    
Market cap (6/24/26): $3.815 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 12 pages Independent Consultant Agreement
12/34/56
EX-10.2
from 8-K 13 pages ***Certain Identified Information Has Been Excluded From the Exhibit Because It Both (I) Is Not Material and (II) Is the Type That the Company Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[...***...]”) in This Exhibit.*** Advisor Agreement
12/34/56
EX-10.1
from 8-K 10 pages Transition and Separation Agreement
12/34/56
EX-10.2
from 10-Q 25 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 15 pages Independent Consultant Agreement
12/34/56
EX-10.27
from 10-K 25 pages Employment Agreement
12/34/56
EX-10.19
from 10-K 3 pages Amendment to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
12/34/56
EX-10.2
from 8-K 10 pages Separation Agreement and General Release
12/34/56
EX-10.1
from 8-K 12 pages Consulting Agreement
12/34/56
EX-10.1
from 10-Q 30 pages Crinetics Pharmaceuticals, Inc. Excess Deferral Plan Adoption Agreement
12/34/56
EX-10.2
from 8-K 47 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 60 pages Securities Purchase Agreement
12/34/56
EX-10.14
from 10-K 5 pages First Amendment to Lease
12/34/56
EX-10.1
from 10-Q 2 pages Amendment to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
12/34/56
EX-10
from 10-Q 4 pages Crinetics Pharmaceuticals, Inc. Non-Employee Director Compensation Program as Amended Effective April 24, 2023
12/34/56
EX-10
from 10-K 2 pages Amendment to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
12/34/56
EX-10.3
from 10-Q 3 pages Amendment to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
12/34/56
EX-10.2
from 10-Q 23 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 109 pages Lease Agreement by and Between San Diego 1 LLC, a Delaware Limited Liability Company, as Landlord, and Crinetics Pharmaceuticals, Inc., a Delaware Corporation, as Tenant 6055 Lusk Boulevard
12/34/56
EX-10.3
from 10-Q 13 pages Consulting Agreement
12/34/56